METRONIDAZOLE | A205245 | SOMERSET THERAPEUTICS LLC
Highest NADAC/Unit
$0.1007
per ea
Lowest NADAC/Unit
$0.1005
per ea
Brand NDCs
0
Generic NDCs
8
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 23155065105METRONIDAZOLE 250 MG TABLET | $0.1007 | EA | Generic | — | 2026-06-17 |
| 00904715661METRONIDAZOLE 250 MG TABLET | $0.1007 | EA | Generic | — | 2026-06-17 |
| 62135079590METRONIDAZOLE 250 MG TABLET | $0.1007 | EA | Generic | — | 2026-06-17 |
| 23155065101METRONIDAZOLE 250 MG TABLET | $0.1007 | EA | Generic | — | 2026-06-17 |
| 62135079690METRONIDAZOLE 500 MG TABLET | $0.1005 | EA | Generic | — | 2026-06-17 |
| 23155065201METRONIDAZOLE 500 MG TABLET | $0.1005 | EA | Generic | — | 2026-06-17 |
| 23155065205METRONIDAZOLE 500 MG TABLET | $0.1005 | EA | Generic | — | 2026-06-17 |
| 00904712661METRONIDAZOLE 500 MG TABLET | $0.1005 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.